Breaking News Instant updates and real-time market news.

GNTX

Gentex

$27.57

-0.01 (-0.04%)

08:05
10/18/19
10/18
08:05
10/18/19
08:05

Gentex lowers FY19 revenue guidance $1.84B-$1.87B from $1.87B-$1.9B

Consensus $1.88B.

  • 18

    Oct

  • 04

    Nov

GNTX Gentex
$27.57

-0.01 (-0.04%)

02/05/19
LBOW
02/05/19
DOWNGRADE
LBOW
Neutral
Gentex downgraded to Neutral from Buy at Longbow
Longbow analyst Anthony Deem downgraded Gentex to Neutral.
02/05/19
02/05/19
DOWNGRADE

Neutral
Gentex downgraded to Neutral on slowing growth at Longbow
As previously reported, Longbow analyst Anthony Deem downgraded Gentex to Neutral from Buy, citing his view that growth over market is slowing in the near-term and the pressure he expects on gross margins from tariffs and price downs that are not fully offset by lower purchase costs. He also believes new products, such as dimmable glass, are unlikely to be material revenue generators for about 5 years, Deem tells investors.
10/15/19
GUGG
10/15/19
INITIATION
Target $29
GUGG
Buy
Gentex initiated with a Buy at Guggenheim
Guggenheim analyst Ali Faghri initiated coverage of Gentex with a Buy rating and $29 price target.
10/16/19
GUGG
10/16/19
INITIATION
GUGG
Guggenheim initiates Auto Suppliers with cautious sector view
Guggenheim analyst Ali Faghri initiated coverage last night on the Auto Suppliers with a cautious sector view. The automotive sector is facing increasing cyclical pressures globally, says Faghri, who forecasts flat to negative global industry production volumes through 2021. This creates a challenging operating environment for auto suppliers, the analyst tells investors in a research note. Faghri believes Europe represents the most significant risk to the group's outlook, pointing out that his work suggests "macro headwinds and disruptive emissions regulations will significantly impact vehicle demand in the region over the next few years." The analyst initiated coverage of Aptiv (APTV) and Gentex (GNTX) with Buy ratings. For Aptiv, he sees high single-digit organic growth through 2022 driven by active safety and electric vehicle content gains. For Gentex, the analyst sees upside to 2019 consensus due to stronger gross margins and visibility for continued above market growth. Faghri rounded out his coverage with Neutral ratings on BorgWarner (BWA), Delphi Technologies (DLPH), Lear (LEA), Visteon (VC) and Veoneer (VNE).

TODAY'S FREE FLY STORIES

THTX

Theratechnologies

$3.05

-0.01 (-0.33%)

07:36
12/13/19
12/13
07:36
12/13/19
07:36
Hot Stocks
Theratechnologies reports results from in vitro, in vivo experiments on TH-1902 »

Theratechnologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HWC

Hancock Whitney

$42.61

1.07 (2.58%)

07:35
12/13/19
12/13
07:35
12/13/19
07:35
Upgrade
Hancock Whitney rating change  »

Hancock Whitney upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GE

General Electric

$11.44

0.46 (4.19%)

, ATVI

Activision Blizzard

$58.60

2.12 (3.75%)

07:35
12/13/19
12/13
07:35
12/13/19
07:35
Options
Unusual call flow in option market yesterday »

Notable call activity was…

GE

General Electric

$11.44

0.46 (4.19%)

ATVI

Activision Blizzard

$58.60

2.12 (3.75%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

  • 29

    Jan

NPO

EnPro

$66.48

2.53 (3.96%)

07:34
12/13/19
12/13
07:34
12/13/19
07:34
Conference/Events
EnPro to host conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BIIB

Biogen

$293.92

1.71 (0.59%)

07:33
12/13/19
12/13
07:33
12/13/19
07:33
Hot Stocks
Breaking Hot Stocks news story on Biogen »

Biogen to discontinue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BIIB

Biogen

$293.92

1.71 (0.59%)

07:32
12/13/19
12/13
07:32
12/13/19
07:32
Hot Stocks
Biogen: Primary endpoint not statistically significant in Phase 2 PASSPORT study »

Biogen announced topline…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADBE

Adobe

$305.76

2.01 (0.66%)

07:32
12/13/19
12/13
07:32
12/13/19
07:32
Recommendations
Adobe analyst commentary  »

Adobe price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

CG

Carlyle Group

$29.83

-0.36 (-1.19%)

07:31
12/13/19
12/13
07:31
12/13/19
07:31
Hot Stocks
Funds advised by Apax Partners to acquire Coalfire from Carlyle Group, Chertoff »

Funds advised by Apax…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

ADBE

Adobe

$305.76

2.01 (0.66%)

07:30
12/13/19
12/13
07:30
12/13/19
07:30
Recommendations
Adobe analyst commentary  »

Adobe price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

SAFM

Sanderson Farms

$166.66

2.5 (1.52%)

07:30
12/13/19
12/13
07:30
12/13/19
07:30
Initiation
Sanderson Farms initiated  »

Sanderson Farms initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Dec

ORCL

Oracle

$56.47

0.16 (0.28%)

07:30
12/13/19
12/13
07:30
12/13/19
07:30
Recommendations
Oracle analyst commentary  »

Oracle shares to come…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AVGO

Broadcom

$327.39

7.53 (2.35%)

07:28
12/13/19
12/13
07:28
12/13/19
07:28
Recommendations
Broadcom analyst commentary  »

Broadcom price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NCLH

Norwegian Cruise Line

$56.12

0.72 (1.30%)

07:27
12/13/19
12/13
07:27
12/13/19
07:27
Recommendations
Norwegian Cruise Line analyst commentary  »

Norwegian Cruise Line…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADBE

Adobe

$305.76

2.01 (0.66%)

07:26
12/13/19
12/13
07:26
12/13/19
07:26
Recommendations
Adobe analyst commentary  »

Adobe price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

ADBE

Adobe

$305.76

2.01 (0.66%)

07:25
12/13/19
12/13
07:25
12/13/19
07:25
Recommendations
Adobe analyst commentary  »

Adobe price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

DCP

DCP Midstream

$23.70

-0.56 (-2.31%)

07:25
12/13/19
12/13
07:25
12/13/19
07:25
Initiation
DCP Midstream initiated  »

DCP Midstream initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Jan

07:25
12/13/19
12/13
07:25
12/13/19
07:25
Conference/Events
UBS analyst manley to hold an analyst/industry conference call »

Analyst Manley discusses…

TDOC

Teladoc

$77.06

-0.36 (-0.46%)

07:24
12/13/19
12/13
07:24
12/13/19
07:24
Initiation
Teladoc initiated  »

Teladoc initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AIMT

Aimmune

$31.60

0.78 (2.53%)

07:22
12/13/19
12/13
07:22
12/13/19
07:22
Downgrade
Credit Suisse downgrades Aimmune with peanut allergy approval widely expected »

Credit Suisse analyst…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NDSN

Nordson

$162.94

-4.5 (-2.69%)

07:22
12/13/19
12/13
07:22
12/13/19
07:22
Downgrade
Nordson rating change  »

Nordson downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BLUE

Bluebird Bio

$84.00

-2.97 (-3.42%)

07:20
12/13/19
12/13
07:20
12/13/19
07:20
Upgrade
Bluebird Bio rating change  »

Bluebird Bio upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BMY

Bristol-Myers

07:19
12/13/19
12/13
07:19
12/13/19
07:19
Upgrade
Bristol-Myers rating change  »

Bristol-Myers upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BNS

Bank of Nova Scotia

$56.73

0.145 (0.26%)

07:19
12/13/19
12/13
07:19
12/13/19
07:19
Downgrade
Bank of Nova Scotia rating change  »

Bank of Nova Scotia…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

SKX

Skechers

$41.65

0.89 (2.18%)

07:18
12/13/19
12/13
07:18
12/13/19
07:18
Upgrade
Skechers rating change  »

Skechers upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ETSY

Etsy

$41.97

0.95 (2.32%)

07:17
12/13/19
12/13
07:17
12/13/19
07:17
Initiation
Etsy initiated  »

Etsy initiated with a Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.